Brain metastasis of ovarian cancer after negative second-look laparotomy

We present a case of ovarian carcinoma that had brain metastasis seven months after having a negative second-look laparotomy and 13 months after the onset of diagnosis. Despite intense multidisciplinary treatment with surgery, chemotherapy and radiotherapy, the patient died seven months after second-look laparotomy.

Ovarian carcinoma; Brain metastasis; Second-look laparotomy

[1] Sood A. K., Sorosky J. I., Dolan M., Anderson B., Buller R. E.: "Distant metastases in ovarian cancer: association with p53 mutations". Clin. Cancer Res., 1999, 5, 2485.

[2] Hardy J. R., Harvey V. J.: "Cerebral metastases in patients with ovarian cancer treated with chemotherapy". Gynecol. Oneal., 1989,33, 296.

[3] Stein M., Steiner M., Klein B., Beck D., Atad J., Kuten A. et al.: "Involvement of the central nervous system by ovarian carcinoma". Cancer, 1986, 58, 2066.

[4] Dauplat J., Nieberg R. K., Hacker N. F.: "Central nervous system metastases in epithelial ovarian carcinoma". Cancer, 1987, 60, 2559.

[5] Geisler J.P., Geisler H. E.: "Brain metastases in epithelial ovarian carcinoma". Gynecol. Oneal., 1995, 57, 246.

[6] Larson D. M., Copeland L. J.,M oser R. P.,M alone J.M. Jr., Gershenson D. M, Wharton J. T: "Central nervous system metastases in epithelial ovarian carcinoma". Obstet. Gynecol., 1986, 68, 746.

[7] John A. Rock, John D. Thompson (eds).:'Te Linde's Operative Gynecology". Eighth edition. Philadelphia: Lippincott-Raven, 1997, 51, 1557.

[8] Buchsbaum H. J.. Brady M. F., Delgado G. et al.: "Surgical staging of carcinoma of the ovaries". Surg. Gynecol. Obstet., 1989, 169.

[9] LeRoux P. D., Berger M. S., Elliott J.P., Tamimi H.K.: "Cerebral metastases from ovarian carcinoma". Cancer. 1991, 67, 2194.

[10] Deutsch M., Beck D.. Manor D.. Brandes J.: "Metastatic brain tumor following negative second-look operation for ovarian carcinoma". Gynecol. Oneal., 1987, 27, 116.

[11] Suzuki M., Tsukagoshi S.、Ohwada M.,K oumura Y., Sato I.: "A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment". Gynecol Oneal.. 1999., 74,483.

[12] Cormio G.. Gabriele A., Maneo A., Zanetta G.. Bonazzi C.. Landoni F.: "Complete remission of brain metastases from ovarian carcinoma with carboplatin". Eur. J. Obstet. Gynecol. Reprod. Biol.,1998, 78, 91.

[13] Vlasveld L. T., Beynen J. H., Boogerd W., Ten Bokkel Huinink W. W., Rodenhuis S.: "Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study". Cancer Chemothe1: Pharmacol., 1990, 25, 382.

[14] Heimans J. J.. Vermorken J. B., Wolbers J. G., Eeltink C. M., Meijer O. W., Taphoorn M. J., Beijnen J. H.: "Paclitaxel (Taxol) concentrations in brain tumor tissue". Ann. Oneal., 1994, 5, 951.

[15] Glantz M. J.,C hoy H.,K earns C. M.,M ills P. C., Wahlberg L. U., Zuhowski E. G. et al.: "Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors". Cancer Inst., 1995, 87, 1077.

[16] Thomas H. D., Lind M. J.. Ford J., Bleehen N., Calvert A. H., Boddy A. V.: "Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours". Cancer Chemotha Pharmacol., 2000, 45, 284.

[17] Emerich D. F., Snodgrass P.. Dean R., Agostino M., Hasler B., Pink M. et al.: "Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters". Br. J. Cancer, 1999, 80, 964.

[18] Hardy J. R., Harvey V. J.: ··cerebral metastases in patients with ovarian cancer treated with chemotherapy". Gynecol. Oneal., 1989,33, 296.